Mohannad Abu-Hilal1, Jayant Tawaker. 1. Department of Internal Medicine, Division of Gastroenterology, Mayo Clinic College of Medicine, Rochester, MN 55902, USA. abuhilal.mohannad@yahoo.com
Abstract
AIM: To describe the clinical presentation and complications of portal hypertension (PH) secondary to myelofibrosis with myeloid metaplasia (MMM). METHODS: Medical records for 123 patients with MMM were reviewed. RESULTS: Thirteen patients with PH secondary to MMM were identified. Median ages at time of MMM and PH diagnosis were 61 and 66 years, respectively. The interval from MMM diagnosis to presentation with one of the PH features ranged from 1 to 11 years. Variceal bleeding and ascites were the most common presentations. Of the eight patients who presented with variceal bleeding, six patients underwent endoscopic variceal ligation (EVL) with no variceal recurrence or hematological worsening during a 12-mo follow up period. CONCLUSION: Patients with MMM might develop PH. Exact mechanisms leading to PH in MMM are still controversial. As in other etiologies, variceal bleeding and ascites are the most common presentations. Anemia may correlate with, and/or predict, the severity of the PH presentation in these patients. EVL can successfully control variceal bleeding in MMM. Further clinical studies are required.
AIM: To describe the clinical presentation and complications of portal hypertension (PH) secondary to myelofibrosis with myeloid metaplasia (MMM). METHODS: Medical records for 123 patients with MMM were reviewed. RESULTS: Thirteen patients with PH secondary to MMM were identified. Median ages at time of MMM and PH diagnosis were 61 and 66 years, respectively. The interval from MMM diagnosis to presentation with one of the PH features ranged from 1 to 11 years. Variceal bleeding and ascites were the most common presentations. Of the eight patients who presented with variceal bleeding, six patients underwent endoscopic variceal ligation (EVL) with no variceal recurrence or hematological worsening during a 12-mo follow up period. CONCLUSION:Patients with MMM might develop PH. Exact mechanisms leading to PH in MMM are still controversial. As in other etiologies, variceal bleeding and ascites are the most common presentations. Anemia may correlate with, and/or predict, the severity of the PH presentation in these patients. EVL can successfully control variceal bleeding in MMM. Further clinical studies are required.
Authors: N Tanaka; K Yamakado; H Kihira; A Hashimoto; T Murayama; K Takeda Journal: Cardiovasc Intervent Radiol Date: 2000 Nov-Dec Impact factor: 2.740
Authors: Gheorghe Ghidirim; Ion Corchmaru; Igor Mishin; Alexander Danch; Gheorghe Zastavnitsky Journal: J Gastrointestin Liver Dis Date: 2006-09 Impact factor: 2.008
Authors: Antonia Perelló; Juan Carlos García-Pagán; Rosa Gilabert; Yanette Suárez; Eduardo Moitinho; Francisco Cervantes; Juan Carlos Reverter; Angels Escorsell; Jaume Bosch; Juan Rodés Journal: Hepatology Date: 2002-01 Impact factor: 17.425
Authors: R Wiest; U Strauch; H Wagner; M Strotzer; M Woenckhaus; G Schröder; J Schölmerich; G Lock Journal: Scand J Gastroenterol Date: 2004-04 Impact factor: 2.423
Authors: Ankur Varma; Susan C Abraham; Rohtesh S Mehta; Neeraj Y Saini; Medhavi Honhar; Munazza Rashid; Julianne Chen; Samer A Srour; Qaiser Bashir; Gabriela Rondon; Betul Oran; Chitra M Hosing; Yago Nieto; Partow Kebriaei; Amin M Alousi; Sairah Ahmed; David Marin; Issa F Khouri; Stefan O Ciurea; Muzaffar H Qazilbash; Katy Rezvani; Paolo Anderlini; Borje S Andersson; Elizabeth J Shpall; Richard E Champlin; Uday R Popat Journal: Blood Adv Date: 2020-04-14
Authors: Ken Ogasawara; William B Smith; Christine Xu; Jian Yin; Maria Palmisano; Gopal Krishna Journal: Cancer Chemother Pharmacol Date: 2020-05-24 Impact factor: 3.333
Authors: Debanjali Mitra; James A Kaye; Lance T Piecoro; Jennifer Brown; Kelly Reith; Tariq I Mughal; Nicholas J Sarlis Journal: Cancer Med Date: 2013-10-05 Impact factor: 4.452